Cushionflor by Congoleum

Product Description

Cushionflor was a resilient sheet flooring product manufactured by Congoleum Corporation, one of the largest floor covering companies in the United States throughout much of the twentieth century. Marketed primarily as a durable, cushioned vinyl flooring solution for residential and commercial applications, Cushionflor was designed to offer comfort underfoot, ease of installation, and resistance to moisture and heavy foot traffic. The product was sold in wide rolls and could be cut to fit virtually any room configuration, making it a popular choice for kitchens, bathrooms, utility rooms, and industrial facilities where a continuous, seamless floor surface was preferred over individual tiles.

Congoleum built its reputation on resilient flooring products, and Cushionflor represented one of the company’s efforts to combine aesthetic flexibility with practical durability. The sheet flooring format distinguished it from the company’s separate line of individual floor tiles, as the continuous backing material and layered construction allowed for different manufacturing inputs than tile products. Cushionflor was distributed through flooring retailers, building supply dealers, and wholesale channels, reaching both the do-it-yourself consumer market and professional installation contractors across the country.

The product’s layered construction — typically involving a decorative wear layer bonded to a backing or cushioning substrate — reflected manufacturing practices common to the resilient flooring industry during the mid-to-late twentieth century. It is within these backing and substrate layers, as well as in the adhesive compounds recommended for installation, that asbestos-containing materials became part of the product’s documented history.

Asbestos Content

Litigation records document that Cushionflor contained asbestos-containing materials as part of its manufacturing composition. Plaintiffs alleged that asbestos fibers were incorporated into the backing and cushioning substrate layers of the sheet flooring product, consistent with industry-wide practices in resilient flooring manufacturing during the relevant production period. Asbestos was used in these applications because of its heat resistance, dimensional stability, and ability to reinforce flexible backing materials without significantly adding to their weight or thickness.

Plaintiffs further alleged that asbestos-containing adhesives — also known as asbestos floor cements or cutback adhesives — were specified or recommended for use in installing Cushionflor products. These adhesives were separately manufactured but were frequently supplied or recommended as part of the complete flooring installation system. Litigation records document claims that exposure hazards arose not only from the sheet flooring material itself but also from the adhesive compounds used to bond it to subfloor surfaces.

The combination of asbestos in both the product substrate and the associated installation adhesives meant that workers involved in installation, maintenance, renovation, and removal faced potential exposure at multiple points throughout the product’s service life. Litigation records document that plaintiffs alleged Congoleum was aware, or should have been aware, of the hazards associated with asbestos in its flooring products and failed to provide adequate warnings to workers and consumers.

How Workers Were Exposed

Industrial workers generally represent the primary exposure category documented in litigation involving Cushionflor. The nature of sheet flooring installation, maintenance, and removal created multiple pathways through which airborne asbestos fibers could be released and inhaled.

Installation workers faced exposure during the cutting and trimming of Cushionflor sheet material to fit floor dimensions. Cutting operations using utility knives, snips, or power cutting tools abraded the backing and substrate layers, potentially releasing asbestos fibers into the breathing zone of the installer. Litigation records document that workers performing these tasks in confined or inadequately ventilated spaces faced elevated exposure risks.

Adhesive mixing and application represented a separate and significant exposure pathway. Plaintiffs alleged that workers who mixed powdered asbestos-containing floor cement, spread cutback adhesive, or worked in proximity to freshly applied adhesive compounds were exposed to asbestos fibers released during those activities. The application of adhesive with notched trowels across large floor areas created conditions under which fiber release could be sustained over extended work periods.

Renovation and removal workers faced particularly significant exposures, as litigation records document claims arising from the disturbance of existing Cushionflor installations during building rehabilitation, remodeling, and demolition activities. Breaking up bonded sheet flooring, scraping residual adhesive from subfloor surfaces, and grinding down adhesive residue were among the operations plaintiffs alleged generated high concentrations of airborne asbestos dust. These activities were common in industrial facilities undergoing periodic renovation or in residential properties being upgraded.

Maintenance personnel in industrial settings — including plant workers, janitors, and facilities maintenance staff — who worked in areas where Cushionflor had been installed could face incidental exposure if the flooring was in a deteriorated or damaged condition, or if maintenance activities disturbed the flooring surface or underlying adhesive layer.

The occupational categories most frequently appearing in litigation records related to Cushionflor and similar resilient sheet flooring products include flooring installers, general construction laborers, tile and resilient floor layers, industrial maintenance workers, renovation contractors, and demolition workers.

Because Congoleum Corporation is identified as a Tier 2 litigated product manufacturer for purposes of this reference article, claims related to Cushionflor are pursued through the civil litigation system rather than through an established asbestos bankruptcy trust fund.

Civil Litigation

Litigation records document that plaintiffs diagnosed with mesothelioma, lung cancer, asbestosis, and other asbestos-related diseases have brought claims against Congoleum in connection with its asbestos-containing flooring products, including sheet flooring products such as Cushionflor. Plaintiffs alleged theories of negligence, failure to warn, strict products liability, and, in some cases, fraud based on alleged concealment of known hazards. Litigation records document that claims were brought both by workers directly involved in Cushionflor installation and removal, and by workers who alleged bystander or secondary exposure in environments where the flooring was disturbed.

Steps for Affected Individuals

Individuals diagnosed with an asbestos-related disease who have a documented history of exposure to Cushionflor or other Congoleum asbestos-containing flooring products should:

  1. Consult a qualified asbestos litigation attorney experienced in product identification and occupational exposure cases. Many asbestos law firms offer free case evaluations.
  2. Document employment and exposure history, including worksites, job titles, and any known use of Congoleum flooring products or related adhesives.
  3. Preserve medical records, including pathology reports, imaging studies, and physician diagnoses relevant to any asbestos-related condition.
  4. Identify co-defendant exposure sources, as asbestos disease cases frequently involve multiple products and manufacturers. An experienced attorney can identify all potentially liable parties, including adhesive manufacturers and premises owners.

Statutes of limitations for asbestos-related claims vary by state and typically begin running from the date of diagnosis rather than the date of exposure. Early consultation with legal counsel is strongly advised to preserve all available legal remedies.